Journal Highlight : Targeted Drug Therapy
The journal welcomes scholarly contributions related to the development and application of therapies designed to specifically target molecular pathways, cellular mechanisms, and disease-associated biomarkers. This section focuses on research that advances precision-based treatment strategies to improve therapeutic efficacy, reduce adverse effects, and enhance patient outcomes across diverse disease conditions.
The journal encourages submissions in areas including Targeted Drug Therapy, Precision and Personalized Medicine, Molecular Therapeutics, Biomarker-Guided Treatment Strategies, Small Molecule Inhibitors, Monoclonal Antibody Therapies, Gene and RNA-Based Therapeutics, Cellular Therapies, and Immunotherapeutic Approaches. Research related to Cancer Targeted Therapy, Targeted Antimicrobial and Antiviral Treatments, Signal Transduction Inhibitors, Nanotechnology-Based Therapeutics, Biologics and Biosimilars, and Advanced Drug Delivery Systems is also welcomed.
Submissions focusing on Therapeutic Target Identification and Validation, Drug Resistance Mechanisms, Combination and Multi-Targeted Therapies, AI and Computational Therapeutic Design, Pharmacogenomics, Translational and Clinical Therapeutics, Precision Pharmacology, and Clinical Trials of Targeted Treatments are encouraged. The journal also welcomes studies investigating therapeutic optimization, molecular treatment responses, safety evaluation, and innovative approaches for disease-specific targeted interventions.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental and Clinical Studies, Preclinical Therapeutic Research, Methodology and Technology Articles, and Translational Pharmaceutical Studies that contribute to advancements in targeted therapeutics.
Through this focus area, the journal aims to support research that advances precision therapeutic strategies, strengthens translational pharmaceutical and biomedical innovation, improves treatment specificity and effectiveness, and contributes to progress in modern drug discovery and personalized healthcare worldwide.
